Artrya Company Description

Artrya Limited, a medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.

The company offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack.

Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Artrya Limited

Country	Australia
Founded	2018
Industry	Health Information Services
Sector	Healthcare
CEO	Mathew Regan

Contact Details

Address: 1257 Hay Street West Perth, 6005 Australia
Phone	61 8 6478 7816
Website	artrya.com

Stock Details

Ticker Symbol	AYA
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU0000182412
SIC Code	7372

Key Executives

Name	Position
Ted Schwab	Co-Chief Executive Officer of Artrya USA Inc
Mathew Regan	Chief Executive Officer
John Konstantopoulos B.E.	Co-Founder and Executive of Commercial and Strategy
Mark Wainwright	Chief Financial Officer
Prof. Girish Dwivedi M.D.	Chief Scientific Officer
Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A.	Company Secretary